236 related articles for article (PubMed ID: 28579773)
1. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Sun X; Liu B; Xu M; He B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1549-1564. PubMed ID: 28579773
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
[TBL] [Abstract][Full Text] [Related]
4. Anti-
Banerjee S; Bhattacharyya P; Mitra S; Kundu S; Panda S; Chatterjee IB
Int J Chron Obstruct Pulmon Dis; 2017; 12():1847-1856. PubMed ID: 28684907
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
6. MFG-E8, a clearance glycoprotein of apoptotic cells, as a new marker of disease severity in chronic obstructive pulmonary disease.
Zhang S; Xie JG; Su BT; Li JL; Hu N; Chen J; Luo GW; Cui TP
Braz J Med Biol Res; 2015 Nov; 48(11):1032-8. PubMed ID: 26375445
[TBL] [Abstract][Full Text] [Related]
7. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.
Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903
[TBL] [Abstract][Full Text] [Related]
9. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
[TBL] [Abstract][Full Text] [Related]
12. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
[TBL] [Abstract][Full Text] [Related]
13. A score to predict short-term risk of COPD exacerbations (SCOPEX).
Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
[TBL] [Abstract][Full Text] [Related]
14. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
15. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
16. Heart Rate Recovery After 6-min Walking Test Predicts Acute Exacerbation in COPD.
Rodríguez DA; Kortianou EA; Alison JA; Casas A; Giavedoni S; Barberan-Garcia A; Arbillaga A; Vilaró J; Gimeno-Santos E; Vogiatzis I; Rabinovich R; Roca J
Lung; 2017 Aug; 195(4):463-467. PubMed ID: 28624883
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan 4 is a diagnostic biomarker for COPD.
Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
[TBL] [Abstract][Full Text] [Related]
20. Palliative care and prognosis in COPD: a systematic review with a validation cohort.
Almagro P; Yun S; Sangil A; Rodríguez-Carballeira M; Marine M; Landete P; Soler-Cataluña JJ; Soriano JB; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1721-1729. PubMed ID: 28652724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
